An exclusive interview with Serge Saxonov of 10x Genomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.

10x Genomics has agreed to acquire Scale Biosciences in a cash-and-stock deal worth $30 million. The life science technology company said Thursday the deal also includes contingent consideration that ...